BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different

No longer is histology solely predictive of cancer treatment and outcome. There is an increasing influence of tumor genomic characteristics on therapeutic options. Both breast and ovarian cancers are at higher risk of development in patients with BRCA 1/2-germline mutations. Recent data from The Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, Melissa, Puhalla, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936197/
https://www.ncbi.nlm.nih.gov/pubmed/24579064
http://dx.doi.org/10.3389/fonc.2014.00019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936197/
https://www.ncbi.nlm.nih.gov/pubmed/24579064
http://dx.doi.org/10.3389/fonc.2014.00019

Ejemplares similares